Total investments received (USD): 32.09m
Round value (USD): 6.63m
Company: Cellcolabs
Industry:
Biotech
Health services






Belgium
Netherlands
Austria
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Portugal
Spain
United Kingdom